Reply to: “MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: Implications for assessing therapeutic response”

Journal of Hepatology 2026 Open access

Read full text

Authors: Carolin Lackner, Annette S.H. Gouw, DINA G. TINIAKOS

DOI: 10.1016/j.jhep.2025.12.020

Cited by: 0

References: 6

Fields of Study & Subjects

Cystic Fibrosis Research Advances Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Dysphagia Assessment and Management

References 6